Ike,
1. I think VASO is a great bargain, though don't know if I'd classify it as a biotech. More of a medical devices co. I also think GZTC is a great buy here, as is Ligand, even though it is up quite a bit.
2. It is a tough call, as oil can go up in price without the stocks necessarily following. However, using your scenario, I would buy XOI calls in my 90/10, going out to March and somewhat out of the money.
3. BR has some of the world's largest natural gas reserves, thus the classification as a producer as opposed to a service or refining co. However, these classifications are very subjective. Exxon has huge reserves, but it is even larger as a refiner and distributor. UCL is better known as a refiner, but its reserves are huge-mongous. |
